Cesarean section and the risk of allergic rhinitis in children: a systematic review and meta-analysis

Zixin Liu1,2, Li Xie1, Xiaohua Liu1,3

  • 1Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, 410013, Hunan, China.

Scientific Reports
|October 26, 2023
PubMed

Insights

Cesarean section (C-section) delivery is linked to an increased risk of allergic rhinitis (AR) in children. Elective C-sections and those in families with allergy history show a higher AR risk in offspring.

Area of Science:

  • Immunology
  • Pediatrics
  • Public Health

Background:

  • Perinatal factors significantly influence immune development and offspring allergy risk.
  • Allergic rhinitis (AR) is a common condition with potential links to birth mode.

Purpose of the Study:

  • To systematically review and meta-analyze studies on the association between cesarean section (C-section) and offspring AR risk.
  • To investigate the impact of different C-section modes on AR development in children.

Main Methods:

  • Systematic review and meta-analysis of 22 studies including 1,464,868 participants, published before August 1, 2022.
  • Searched major databases (PubMed, Web of Science, EMBASE, etc.) for relevant articles.
  • Statistical analysis using RevMan5.4, including meta-regression and subgroup analyses to assess heterogeneity and publication bias.

Main Results:

  • A significant correlation was found between C-section and childhood AR (OR = 1.19, 95% CI: 1.12-1.27).
  • C-section with a family history of allergy showed a markedly higher AR risk (OR = 1.82, 95% CI: 1.36-2.43).
  • Elective C-sections presented a higher risk of offspring AR (OR = 1.24, 95% CI: 1.05-1.46) compared to the overall C-section group.

Conclusions:

  • Cesarean delivery, particularly elective C-sections and those in families with allergy history, increases the risk of allergic rhinitis in children.
  • Findings highlight the importance of considering birth mode in the context of immune development and allergy prevention strategies.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
301
Allergic Reactions02:06

Allergic Reactions

Overview
27.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458